Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study
Titel:
Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study
Auteur:
Orkin, Chloe Oka, Shinichi Philibert, Patrick Brinson, Cynthia Bassa, Ayesha Gusev, Denis Degen, Olaf García, Juan González Morell, Enrique Bernal Tan, Darrell H S D'Amico, Ronald Dorey, David Griffith, Sandy Thiagarajah, Shanker St Clair, Marty Van Solingen-Ristea, Rodica Crauwels, Herta Ford, Susan L Patel, Parul Chounta, Vasiliki Vanveggel, Simon Cutrell, Amy Van Eygen, Veerle Vandermeulen, Kati Margolis, David A Smith, Kimberly Y Spreen, William R